pyrroles has been researched along with Retinal Neovascularization in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dan, H; Huang, X; Lei, X; Ma, N; Shen, Y; Xing, Y | 1 |
Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, MS; Patel, V; Savsani, H | 1 |
Chavakis, T; Economopoulou, M; Garcia-Martin, R; Grossklaus, S; Klotzsche-von Ameln, A; Mitroulis, I; Sprott, D; Troullinaki, M | 1 |
Allimuthu, J; Chen, FK; Da Cruz, L; Esposti, SD; Keane, PA; Patel, PJ; Tah, V; Tufail, A | 1 |
Cao, R; Cao, Y; Hauptmann, G; Jensen, LD; Söll, I | 1 |
Caldwell, RB; Ju, M; McMahon, G; Robinson, GS; Shih, SC; Smith, LE; Xu, X | 1 |
6 other study(ies) available for pyrroles and Retinal Neovascularization
Article | Year |
---|---|
CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hyperoxia; Indoles; Mice, Inbred C57BL; Neovascularization, Physiologic; Protein Kinase Inhibitors; Pyrroles; Pyrrolidines; Retinal Neovascularization; Retinopathy of Prematurity; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2 | 2021 |
Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chick Embryo; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Female; Hyperoxia; Intercellular Adhesion Molecule-1; Male; Neovascularization, Physiologic; Oxidative Stress; Phenylpropionates; PPAR alpha; PPAR gamma; Pyrroles; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Retina; Retinal Neovascularization; Retinal Vessels; Signal Transduction; Streptozocin; Transcription Factor RelA | 2021 |
53BP1 Deficiency Promotes Pathological Neovascularization in Proliferative Retinopathy.
Topics: Animals; Apoptosis; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Genetic Predisposition to Disease; Homologous Recombination; Humans; Mice, Knockout; Morpholines; Phenotype; Pyrroles; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Signal Transduction; Tumor Suppressor p53-Binding Protein 1 | 2019 |
Repeatability of retinal thickness and volume metrics in neovascular age-related macular degeneration using the Topcon 3DOCT-1000.
Topics: Aged; Aged, 80 and over; Algorithms; Contrast Media; Cyclic N-Oxides; Female; Humans; Macular Degeneration; Male; Middle Aged; Pyrroles; Reproducibility of Results; Retina; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence | 2014 |
Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Green Fluorescent Proteins; Humans; Hypoxia; Indoles; Microscopy, Confocal; Neovascularization, Pathologic; Pyrroles; Receptors, Notch; Retinal Diseases; Retinal Neovascularization; Signal Transduction; Sunitinib; Vascular Endothelial Growth Factor A; Zebrafish | 2008 |
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.
Topics: Angiogenesis Inhibitors; Animals; Humans; Immunohistochemistry; In Situ Hybridization; Indoles; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Proto-Oncogene Proteins; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retina; Retinal Neovascularization; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor Receptor-1 | 2001 |